User menu

Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.

Bibliographic reference Horsmans, Yves ; Desager, Jean-Pierre ; Harvengt, C.. Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin.. In: Pharmacology & toxicology, Vol. 71, no. 4, p. 258-61 (1992)
Permanent URL http://hdl.handle.net/2078.1/24653
  1. Aoyama, Endocrinology, 126, 3101 (1990)
  2. Brian, Biochemistry, 29, 11280 (1990)
  3. Breimer, Pharmacol Therap, 44, 445 (1989)
  4. Eichelbaum, Pharmacol Therap, 46, 377 (1990)
  5. Ged C, Rouillon JM, Pichard L, Combalbert J, Bressot N, Bories P, Michel H, Beaune P, Maurel P, The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction., 10.1111/j.1365-2125.1989.tb03516.x
  6. Guengerich, J. Biol. Chem., 261, 5051 (1986)
  7. Guengerich, Mol. Pharmacol., 30, 287 (1986)
  8. Guengerich, Mol. Pharmacol., 33, 500 (1988)
  9. Guengerich, Annu. Rev. Pharmacol. Toxicol., 29, 241 (1989)
  10. Imaoka, J. Pharmacol. Exp. Therap., 255, 1385 (1990)
  11. Kleinbloesem, Biochem. Pharmacol., 33, 3721 (1984)
  12. Kronbach Thomas, Fischer Volker, Meyer Urs A, Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs, 10.1038/clpt.1988.87
  13. Kronbach, Mol. Pharmacol., 36, 89 (1989)
  14. Loiseleur, Techniques de laboratoire (chimie clinique)., 119 (1954)
  15. Meyer, Pharmacol. Therap., 46, 297 (1990)
  16. Nebert, DNA Cell. Biol., 10, 1 (1991)
  17. Ohnhaus, Eur. J. Clin. Pharmacol., 36, 39 (1989)
  18. Pal, Metabolism, 27, 1003 (1978)
  19. Reeves, Laboratory methods in antimicrobial chemotherapy. (1978)
  20. Schellens, Biochem. Pharmacol., 37, 2507 (1988)
  21. Silber, J. Biol. Chem., 210, 923 (1954)
  22. Shimada, Proc. Nat. Acad. Sci. U.S.A., 86, 462 (1989)
  23. Thrasher, Steroids, 14, 455 (1969)
  24. Vesell Elliot S, Selection of subjects for investigation of host factors affecting drug response: A method to identify new pharmacogenetic conditions, 10.1038/clpt.1984.1
  25. Watkins, Proc. Natl. Acad. Sci. USA, 82, 6310 (1987)
  26. Watkins, J. Clin. Invest., 83, 688 (1989)
  27. Watkins Paul B, Hamilton Ted A, Annesley Thomas M, Ellis Charles N, Kolars Joseph C, Voorhees John J, The erythromycin breath test as a predictor of cyclosporine blood levels, 10.1038/clpt.1990.126
  28. Waxman, Arch. Biochem. Biophys., 263, 424 (1988)
  29. Wilkinson, Pharmacol. Therap., 43, 53 (1989)
  30. Wrighton, Mol. Pharmacol., 36, 97 (1989)
  31. Wrighton, Mol. Pharmacol., 38, 207 (1990)
  32. Zhiri, Clin. Chim. Acta, 157, 267 (1986)